This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

News Articles

New Head of Division for Medical Sciences, University of Oxford

Emeritus Professor of Clinical Neurology, Professor Christopher Kennard joins the Medical Sciences Division as its new interim Head of Division today, replacing Professor Alastair Buchan, who will be taking a new role as the University’s Head of Brexit Strategy. For the full story on University of Oxford website

Consortium rewarded $8.6m grant from the National Institutes of Health

A consortium directed by Dr. Kalyanam Shivkumar at UCLA has received a three-year, $8.6 million grant from the National Institutes of Health (NIH). The consortium hopes to map the heart’s nervous system, ultimately developing new treatments for cardiovascular disease. For the full story on department of physiology, anatomy and genetics website

Researchers offer hope for cure for some causes of schizophrenia

A study led by Dr Belinda Lennox, a consultant psychiatrist at Oxford Health, has found that specific antibodies (proteins usually produced by the body in response to a foreign threat) are associated with the start of schizophrenia. The study, published in the journal Lancet Psychiatry, is the first to identify this association. Full story on Oxford […]

Funding boost for genetics centre

A major University of Oxford genetics research centre that supports Oxford BRC research is to share £118m of new funding. Full story on NIHR Oxford Biomedical Research Centre website

Nanopore genetics breakthrough supported by Oxford BRC

Oxford University’s Wellcome Trust Centre for Human Genetics (WTCHG) and the leading genome analytics company Genomics plc has announced the first sequencing and analysis of multiple human genomes using nanopore technology. The announcement, made on Thursday, December 1, at the Oxford Nanopore Community Meeting in New York City, marks a major breakthrough in sequencing technology. […]

IKAlliance Kick-off Meeting in Brazil

The IKAlliance, a multinational and multidisciplinary consortium created in response to a Horizon 2020 funding call by the European Commission’s Directorate-General Research and Innovation, has officially started its activities with the kick-off meeting held in Brazil over the 4th and 5th December 2016. Full story on Nuffield Department of Medicine website

EnzBond launches to make fast, effective enzyme development realisty

EnzBond, a new biotechnology company from Oxford University, has been formed to commercialise in-silico technology, which makes utilising enzymes in drug manufacturing both cost-effective and time-efficient Full story on Oxford University website

More global investors back Oxford ideas and Britain’s technology future

Oxford University, on behalf of Oxford Sciences Innovation (OSI), has announced a substantial increase of capital raised worldwide to scale innovative ideas from the University of Oxford into world-class companies. Full story on Oxford University website

Study highlights heart disease risk for pregnant women

The latest annual report into maternal deaths, produced by Oxford University researchers, highlights the risk of heart disease among pregnant women. Full story on Oxford University website